Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium – August 11, 2025, 7:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives
‘Dongji Rescue’: Humanity forged in blood and fire BEIJING, Aug. 10, 2025 (GLOBE NEWSWIRE) — The film “Dongji Rescue,” based on the 1942 sinking of the Japanese ship Lisbon Maru after it was torpedoed by American forces, is the moving
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea U.S. Commercialization Officially Launched Mont-Saint-Guibert, Belgium – August 8, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)
SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Rubicon Point Partners announced its first close of Rubicon Point Fund II, a real estate investment vehicle targeting special situation opportunities across the West Coast, with a strategic focus on the San
